Kes1 and amino acid homeostasis. (A) WT yeast cells (CTY182) producing Kes1 derivatives (−Dox) and corresponding non-expressing controls (+Dox; 10μg/ml) were analyzed by EM. Representative images are shown (bar = 1μm). Intra-vacuolar vesicular profiles (diameter ~ 350nm) are highlighted by arrows. (B) The ALP-expressing PHY2433 strain (TN124; ) was induced (−Dox), or not (+Dox; 10μg/ml), for Kes1 or kes1Y97F expression. Cultures were maintained at an OD600nm < 0.2 throughout, harvested and assayed for ALP activity. Error bars represent standard deviation. (C) PCA scores plot distinguishing the 1H-NMR metabolic profiles of WT yeast (CTY182) expressing Kes1 or kes1Y97F (− Dox), or not (+Dox). (D) Targeted PCA of individual metabolites was performed for each condition. Reductions in Arg, Asn, Asp, Glu, Gln, Thr, and Trp pools were the major contribution to the variance between conditions of excess Kes1/kes1Y97F and mock controls. (E) WT yeast (CTY182) transformed with YCp(URA3), YCp(PDOX::KES1) or YCp(PDOX::kes1Y97F) were spotted in 10-fold dilution series on media with Dox (10μg/ml) and amino acids (NEQR, 0.2% w/v). (F) atg13Δ yeast co-transformed with YEp(PCUP1::HA-ATG13) and either YCp(PDOX::KES1) or YCp(PDOX::kes1Y97F) were cultured in media containing 10μg/ml Dox. KES1 or kes1Y97F expression was induced for 7 hours (−Dox), or not (+Dox; 10μg/ml), and cells were challenged with CuSO4 (100μM for 1hr) to induce HA-Atg13 expression. HA-Atg13 species were visualized by immunoblotting with anti-HA antibodies. Also see .